COGENTECH CONSORTIUM FOR GENOMIC TECHNOLOGIES Trademark
COGENTECH CONSORTIUM FOR GENOMIC TECHNOLOGIES is a USPTO trademark filed by CONSORTIUM FOR GENOMIC TECHNOLOGIES SOCIETA' BENEFIT SRL IN BREVE "COGENTECH SOCIETA' BENEFIT SRL". Status: Registered.
Trademark Facts
| Mark | COGENTECH CONSORTIUM FOR GENOMIC TECHNOLOGIES |
|---|---|
| Serial Number | 79216194 |
| Registration Number | 5477919 |
| Status | Registered |
| Filing Date | 2017-05-09 |
| Registration Date | 2018-05-29 |
| Mark Type | Stylized |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT), 044 (Medical Services) |
| Owner | CONSORTIUM FOR GENOMIC TECHNOLOGIES SOCIETA' BENEFIT SRL IN BREVE "COGENTECH SOCIETA' BENEFIT SRL" |
| Attorney of Record | Kenneth F. Florek |
| Prosecution Events | 34 |
| Latest Event | INNP on 2026-05-07 |
Goods & Services
[ Pharmaceutical preparations, namely, pharmaceutical preparations for treating cancer, aging related diseases, neurodegeneration and metabolic diseases; veterinary preparations, namely, veterinary preparations for treating cancer; sanitary preparations for medical purposes; dietetic foods adapted for medical use; dietetic beverages adapted for medical purposes; food for babies; plasters for medical purposes; bandages for dressings; material for stopping teeth; dental wax ]; Medical services; veterinary services [ ; hygienic and beauty care for human beings or animals ]; "CONSORTIUM FOR GENOMIC TECHNOLOGIES"; Scientific and technological services, namely, scientific testing and technological research in the field of genomics, proteomics and cancer therapies and aging related diseases, neurodegeneration and metabolic diseases, scientific research, testing and analysis of genetics and proteomics in the food sector for use in tracing food sources and quality, including in animals destined to the food chain for verifying the health status of the animals, and related research and design services; industrial analysis and research services in the field of genomics, cancer therapies, aging related diseases, neurodegeneration and metabolic diseases